Circadian and ultradian cardiovascular rhythmicity in obese children

Christoph Saner1, Giacomo D Simonetti2,3, Elke Wühl4

  • 1University Children's Hospital UKBB, Spitalstrasse 33, CH-4056, Basel, Switzerland.

Insights

Obese children show altered blood pressure and heart rate rhythms compared to healthy children, even without hypertension. These changes in cardiovascular rhythmicity highlight potential health risks associated with childhood obesity.

Area of Science:

  • Cardiovascular physiology
  • Pediatric endocrinology
  • Chronobiology

Background:

  • Altered cardiovascular rhythmicity is linked to diseases with increased cardiovascular risk.
  • Previous studies noted rhythmicity changes in children with hypertension or renal failure.
  • This study specifically investigates cardiovascular rhythmicity in obese children.

Purpose of the Study:

  • To analyze blood pressure (BP) and heart rate (HR) rhythmicity in obese children.
  • To compare rhythmicity parameters between obese children and a healthy reference group.
  • To identify factors influencing cardiovascular rhythmicity in obese children.

Main Methods:

  • 24-hour ambulatory BP measurements were taken in 75 obese children and 150 lean controls.
  • Fourier analysis was used to assess BP and HR rhythmicity (circadian and ultradian).
  • Multivariate regression analysis identified factors explaining rhythmicity variability.

Main Results:

  • Obese children had lower prevalence of 24-h and 6-h BP rhythmicity (p=0.03, p=0.02).
  • HR rhythmicity prevalence was similar between groups.
  • Obese children exhibited delayed 24-h BP and HR acrophases and blunted 24-h HR amplitude, with higher BP Mesor (p<0.0001).

Conclusions:

  • Obese children demonstrate altered prevalence and parameters of circadian and ultradian BP and HR rhythmicity.
  • These alterations are evident compared to a healthy reference group.
  • Findings are independent of pre-existing hypertension in the obese cohort.
Abstract

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.7K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
449
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
4.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
360
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
333